MNPR MONOPAR THERAPEUTICS Investments/Divestments 8-K Filing 2023 - Expansion and Positive Results Monopar Therapeutics announces expansion of radiopharmaceutical collaboration, positive preclinical results, and visibility toward human trials.Get access to all SEC 8-K filings of the MONOPAR THERAPEUTICS